Search results for "Anticoagulation"
New recommendations released on primary prevention of stroke
The updated guideline from the American Heart Association and American Stroke Association addresses lifelong stroke prevention and includes new sex-and gender-specific recommendations.
https://immattersacp.org/weekly/archives/2024/10/29/1.htm
29 Oct 2024
Parsing periop predicaments
Due to a lack of evidence for best perioperative procedures, clinicians have debated for decades how to address circumstances such as stroke or atrial fibrillation.
https://immattersacp.org/archives/2024/07/parsing-periop-predicaments.htm
1 Jul 2024
Women less likely to receive guideline-directed medical therapy after ischemic stroke
Statin, antihypertensive, and anticoagulant prescriptions within 30 days of discharge were less common in women than in men, and women were less likely to be adherent to statins and antihypertensive treatments at one year.
https://immattersacp.org/weekly/archives/2024/10/08/4.htm
8 Oct 2024
Lifestyle, treatment changes for afib
A new atrial fibrillation guideline focuses on early rhythm control and lifestyle changes such as physical activity and weight loss to slow or disrupt the course of the disease.
https://immattersacp.org/archives/2024/09/lifestyle-treatment-changes-for-afib.htm
1 Sep 2024
Periop cardiovascular guideline updated, calls for avoiding overscreening
The American College of Cardiology, American Heart Association, and other societies released new recommendations on evaluating and managing cardiovascular risk in patients undergoing noncardiac surgery.
https://immattersacp.org/weekly/archives/2024/10/01/2.htm
1 Oct 2024
Intervention targeting clinicians did not increase anticoagulation use in patients with afib
Electronic messaging and academic detailing improved clinicians' comfort with prescribing anticoagulation in certain situations, but rates of appropriate anticoagulation for atrial fibrillation did not change significantly, a trial found.
https://immattersacp.org/weekly/archives/2020/02/25/4.htm
25 Feb 2020
Patients with provoked VTE often on anticoagulation longer than recommended
Three variables were associated with receiving anticoagulation for longer than three months after a provoked venous thromboembolism (VTE): direct oral anticoagulant use, history of VTE, and history of myocardial infarction.
https://immattersacp.org/weekly/archives/2022/11/01/4.htm
1 Nov 2022
Amiodarone increases bleeding compared with flecainide or sotalol in patients on anticoagulant therapy
A retrospective analysis of Medicare patients who started an anticoagulant and then amiodarone found that they had a 44% increased risk for bleeding-related hospitalization compared to those on other antiarrhythmics and that this risk was higher with rivaroxaban than apixaban.
https://immattersacp.org/weekly/archives/2023/05/23/1.htm
23 May 2023
Long-term anticoagulation after first unprovoked VTE associated with considerable bleeding risk
Results from a systematic review and meta-analysis provide a framework for clinicians and patients to balance the benefits and harms of extended anticoagulation for unprovoked venous thromboembolism (VTE).
https://immattersacp.org/weekly/archives/2021/09/14/4.htm
14 Sep 2021
Discontinuing OAC associated with heightened risk of recurrent stroke, study finds
Among patients with atrial fibrillation prescribed oral anticoagulation (OAC) after a stroke, recurrent stroke rates were 13.4% versus 6.8% in those who did and did not discontinue OAC therapy, a Danish study found.
https://immattersacp.org/weekly/archives/2024/07/02/4.htm
2 Jul 2024